Donate
|
Resource Hub
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
Wild Poliovirus
Variant Poliovirus (cVDPV)
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Donors
Expenditure Information
News
Media Centre
Take Action
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
Wild Poliovirus
Variant Poliovirus (cVDPV)
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Donors
Expenditure Information
News
Media Centre
Take Action
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resources for Polio Eradicators
>>
Vaccines and logistics
Vaccines and logistics
nOPV2 Safety Monitoring Guidance Manual
nOPV2 Vaccine Handling
nOPV2 Vaccine Management Guidance
nOPV2 vaccine request form – January 2024
french
|
english
|
Global OPV Stockpile Strategy 2022-2026
21st Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 11 October 2022, Geneva, Switzerland
20th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12–13 October 2021, virtual
tOPV request form (for tOPV with a VVM on the label)
spanish
|
english
|
Technical guidance mOPV2 vaccine management, monitoring, removal and disposal – May 2021
mOPV2 vaccine request form – January 2021
french
|
english
|
19th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12–13 October 2020, virtual
18th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 15 October 2019, Geneva, Switzerland
17th Consultation with OPV/IPV Manufacturers and National Authorities for Containment, 9 October 2018, Geneva, Switzerland
Cold chain logistics and vaccine management during SIA – May 2017
english
|
french
|
IPV request form – Dec 2016
english
|
french
|
